Shares in MedPal AI plc advanced 12% to 3.5 pence following the digital health firm’s announcement of its newly launched integrated health platform. The company characterises the system as the
Medical technology
8Articles
Artificial intelligence models designed to interpret medical scans may be fundamentally flawed, producing convincing diagnostic reports based on images that were never actually provided to them. Researchers have identified this
Shares in MedPal AI, the AIM-listed digital health company specialising in artificial intelligence solutions, advanced 26 per cent to 2.99 pence on Tuesday following the release of record dispensing volumes
Convatec, the FTSE 100 medical equipment maker, has recently enhanced its medium-term financial forecasts following strong results linked to increased investment in new product offerings. This positive update comes amidst
Neuralink is reportedly preparing to accelerate manufacturing capabilities for its brain-computer interface devices whilst transitioning towards an automated surgical implantation procedure, according to statements from company co-founder Elon Musk. In
British patients are preparing for a technological leap as Elon Musk’s Neuralink begins its maiden clinical trials in the United Kingdom. With approvals from UK medical regulators now secured, the
Labour’s ambitious plans to modernise the National Health Service will see patients directed to consult an artificial intelligence-driven ‘AI GP’ as their primary healthcare contact point. The groundbreaking initiative, unveiled
Smith & Nephew, one of the world’s oldest and largest medical technology firms, has indicated it may consider a major structural overhaul of its orthopaedics division following years of sluggish
